Searching for Solutions

Now Accepting Scientific Abstract Submissions for 2026

You can submit abstracts online for the 2026 AAPP Annual Meeting from now through January 8, 2026. Accepted abstracts will be displayed during the meeting at the Hyatt Regency Bellevue in Bellevue, Washington, held April 19-22, 2026.

Learn More

AAPP Foundation Board of Directors

If you would like to send a message to the board of directors, please use the contact form or email board@aappfoundation.org.

Cultivating Expertise: Enhancing Presentation Design and Speaker Development in Psychiatric Pharmacists

No summary available

2
hours

Expires: 06/02/2027

Pre-Meeting Workshop - Cultivating Expertise: Enhancing Presentation Design and Speaker Development in Psychiatric Pharmacists

No summary available

4
hours

Expired

Mastering Movement: An Interactive Learning Lab on AIMS Assessment and Tardive Dyskinesia Treatment

No summary available

1.5
hours

Expired

Expedited referrals from community health center to opioid treatment program: innovative approaches to improving access to methadone treatment for patients who use opioids and experience homelessness

Efforts to reduce barriers to methadone initiation via partnerships between mobile health programs, SSPs, and OTPs can be a tool in combating the overdose crisis.

Learn More

Opioid overdose associated with concomitant use of hydrocodone and selective serotonin reuptake inhibitors

In this cohort study, based on data from US healthcare claims databases, initiating citalopram, escitalopram, fluoxetine, or paroxetine while on hydrocodone was associated with an increased risk of opioid overdose compared with sertraline.

Learn More

Breaking barriers: evaluating access models for harm reduction vending machines

Given the high level of stigma and shame experienced by PWUDs, the lowest barrier HRVM access models should be adopted to promote equitable access to harm reduction and basic needs supplies.

Learn More

Integrating Methadone Services Into Primary Care in Ukraine: Two-Year Outcomes From a Randomized Trial

Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care without compromising methadone retention and treatment quality.

Learn More

Buprenorphine Treatment Duration and Adherence Among Youth and Subsequent Health Outcomes

Medication adherence may prevent overdose, ED use, and hospitalization. Strategies to increase treatment duration/adherence likely avert harm.

Learn More

Productivity Losses From Substance Use Disorder in the U.S. in 2023

Total morbidity-related productivity losses attributable to substance use disorder in the U.S. are substantial, amounting to $92.65 billion in 2023.

Learn More

Advocating for the Evidence: Harm Reduction

AAPP supports funding, access, and delivery of harm reduction services to prevent substance-use related injury, disease, overdose, and misuse. Psychiatric pharmacists are encouraged to use this policy brief to support your own advocacy efforts promoting continued delivery of harm reduction services.

Learn More

Grants

No summary available

AAPP 2025 Practice Expansion Grant

The mission of the American Association of Psychiatric Pharmacists (AAPP) is to advance the reach and practice of psychiatric pharmacy and serve as the voice of the specialty to improve the public’s mental health care. Innovative quality improvement projects that support the integration of psychiatric pharmacists into mental health care teams are critical for the advancement of the profession.

Grants

AAPP Outcomes Grant The application portal is OPEN. Deadline: Oct.

AAPP Supports Bipartisan Bill to Eliminate Delays in Accessing Gold Standard Addiction Treatment

U.S. Senators Maggie Hassan (D-NH) and Jim Justice (R-WV) introduced bipartisan legislation to help ensure that people who are struggling with addiction can access life-saving medication-assisted treatment (MAT) – the gold standard of addiction care – without dangerous delays. The No Red Tape for Addiction Treatment Act would eliminate prior authorization requirements for people with Medicaid coverage who need medication-assisted treatment for opioid addiction, removing a bureaucratic barrier that can leave patients waiting days to fill their prescriptions when every moment counts.

The Pleasure Pain Balance in a Dopamine Overloaded World

No summary available

AAPP Outcomes Research Grant Award

In 2023, AAPP committed up to $500,000 to directly support multi-site research related to the impact of psychiatric pharmacists on patient care through the AAPP Foundation. The commitment has funded two major prospective research projects.

Happy Holidays and Best Wishes for the New Year!

AAPP staff, with matching donations from AAPP, donated $850 to adopt a family in Wisconsin for Christmas. CPD Director Beth DeJongh and her Girl Scout troop completed the shopping for a family of seven.

In celebration of the holidays, the AAPP office will be closed from December 24-January 1.

The AAPP Board of Directors and Staff wish you Happy Holidays!